Sarcoma Foundation of America, Inc.

12/22/2025

New findings from the ALBERT trial on immunotherapy for alveolar soft part sarcoma (ASPS)

Researchers at the National Cancer Center Hospital in Japan investigated atezolizumab (an immunotherapy drug) in 20 patients with alveolar soft part sarcoma (ASPS), a rare type of soft tissue cancer.

What they found:
- 2 patients had their tumors completely disappear for over a year.
- 80% of patients saw their disease controlled.
- Patients who responded had more active immune cells (CD8+ T cells) in their tumors before starting treatment.

These immune cells may help doctors predict who will benefit from this treatment.
This study adds important evidence for using immunotherapy in rare cancers and may help identify which patients are most likely to respond. Read the full study: https://www.ejcancer.com/article/S0959-8049(25)00990-6/fulltext

12/19/2025

Get excited! RTCS 2026 is coming soon to a city near you!

Join SFA and over 68,000 RTCS participants nationwide to raise money to support research and those affected by it.

Don’t see your city? Find the full race list here: https://curesarcoma.org/race-to-cure-sarcoma/

12/18/2025

In the face of his sarcoma diagnosis, Todd D. Barron chose hope, compassion, and impact. His generosity and commitment to giving endure, leaving a lasting impact that continues to touch countless lives. Last month, more than 100 friends and family gathered poolside at the home of his wife, Debra Barron, to honor his legacy and raised more than $150,000 to establish the Todd D. Barron Research Fund at SFA.

You too can honor a loved one and help fuel life-saving sarcoma research by hosting your own third-party fundraiser. Learn more at https://www.givesignup.org/Race/MD/Damascus/RaiseYourWay

12/16/2025

Because sarcoma is rare, it’s often overlooked and underfunded, leaving patients with limited treatment options. With major cuts to research funding, rare cancers like sarcoma risk falling even further behind. Research is the path to a cure and the heart of SFA. As the largest private funder of sarcoma research, we are committed to advancing impactful science worldwide, and as we close out 2025, we hope you’ll help us keep this critical work moving forward.

Donate here: curesarcoma.org/year-end

12/15/2025

For patients and families facing sarcoma, hope comes from progress. Federal employees and retirees can help drive that progress by pledging to the Sarcoma Foundation of America through the 2025 Combined Federal Campaign, open until January 15, 2026. CFC #57785.

12/12/2025

Being a care partner leaves a lasting impact. Whether you’re supporting someone now or have in the past, you help hold the sarcoma community together. Every journey is shaped not just by patients, but by the people who walk beside them. Thank you, Sabina, for sharing your experience as a care partner for your daughter, Natasha, during her synovial sarcoma diagnosis.

12/11/2025

Happy holidays from SFA! As we enter the holiday season, we’re grateful for the strength, advocacy, and hope shared across the sarcoma community. Supporting and learning from this community for 25 years has been a true gift, and we are thankful for each of you.

12/09/2025

SFA is now accepting applications for the 2026 Last Mile Sarcoma Research Award. This one-year, $150,000 grant supports sarcoma researchers seeking to strengthen the resubmission of R01 or equivalent proposals focused on advancing the understanding and treatment of sarcoma. Applications are due by February 2, 2026, at 5:00 pm ET.

Find more information here: https://curesarcoma.org/research/funding-opportunities/last-mile-sarcoma-research-award/

12/08/2025

Give something that can’t be bought in stores – the gift of hope. This holiday season donate in honor or memory of a loved one, friend, or colleague and leave a legacy in their name. Turn love into action and help fuel research that can change the future for people affected by . Your donation includes a personalized digital holiday card featuring artwork from SFA’s Sarcoma Awareness Month Children’s Art Program. By giving through SFA, you advance lifesaving research and send a powerful message of your commitment to finding a cure for .

Donate: curesarcoma.org/holiday-gift

12/05/2025

The 2026 Race to Cure Sarcoma season kicks off soon, and South Florida is up first! Lace up your sneakers and get ready to walk or run in support of research. Register today for a meaningful, family-friendly event.

Register here: https://runsignup.com/Race/FL/FortLauderdale/RacetoCureSarcomaSouthFlorida

12/04/2025

SFA is proud to share the new Pushing Ultra-Rare Sarcomas Beyond Hope (PUSH) website. SFA is the administrator of this global collaboration, which brings together clinicians, scientists, and patient advocates working to accelerate research and improve care for people with ultra-rare sarcomas.

Through focused working groups, PUSH brings together people, data, and ideas to advance treatment development and knowledge-sharing worldwide. Visit the new website to learn more about its mission and current initiatives and to find out how to get involved.

PUSH Website: https://push-platform.org

12/03/2025

Our 2025 Courage Award winner, Andrey Ivchenko, recently shared his story with MovieWeb, reflecting on continuing his work on Stranger Things while navigating a chondrosarcoma diagnosis. He also spoke about what it meant to join the SFA community at the Stand Up to Sarcoma Gala and to honor those who supported him throughout treatment.

Read his full interview:

"Everyone welcomed me into the 'Stranger Things' family like I had always been there — I never felt like an outsider."